Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial. - Ahn DH; Ridinger M; Cannon TL; Mendelsohn L; Starr JS; Hubbard JM; Kasi A; Barzi A; Samuëlsz E; Karki A; Subramanian RA; Yemane D; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)